ClinicalTrials.gg
Not yet recruitingNCT07650071PS IVGUpdated Jun 16, 2026

PS IVG : Psychosocial Determinants of Late-term Abortions (14-16 Weeks' Gestation) at Avignon Hospital

An interventional study of Health survey in Psychosocial Health and Abortion, sponsored by Centre Hospitalier Henri Duffaut - Avignon. Not yet recruiting at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-16.

Sponsored by Centre Hospitalier Henri Duffaut - Avignon · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

Abortion is a fundamental right for women in France, where the legal time limit was extended from 14 to 16 weeks' gestation. This extension allows women, whose psychosocial determinants are poorly known, and who face various obstacles (personal, administrative, medical, or other), to access abortion. However, it may also expose them to psychological troubles and difficulties in accessing healthcare. This study aims to identify the psychosocial determinants and disruptions in the primary care pathway associated with late abortions (≥14 weeks' gestation [WG]) in order to propose preventive actions, particularly regarding contraception, screening, and referral, directly applicable in general practice.

02

Conditions studied

  • Psychosocial Health
  • Abortion
03

In context

Lead sponsor

Centre Hospitalier Henri Duffaut - Avignon is the lead sponsor of 10 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient aged ≥ 18 years
  • Pregnancy ≥ 14 weeks' gestation
  • Patient attending Avignon Hospital for a surgical abortion
  • Willing to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Medical abortion (non-surgical means of abortion)
  • Ectopic pregnancy
  • Inability to complete the questionnaire
  • Patients under legal protection measures (guardianship, curatorship, or court-ordered protection)
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Health survey

    This is a health survey. Following patient recruitment, the physician will explain the study and its objectives. If the patient agrees to participate, a QR code will be provided to allow anonymous access to the study questionnaire. The patient will be invited to complete the questionnaire after the medical consultation.

    Behavioral: Health survey

Interventions

  • BehavioralHealth survey

    It consists of a single anonymous questionnaire, to be completed once only, on a secure online platform, accessed using a QR code provided directly by the healthcare professional. The questionnaire consists of 39 main questions, predominantly with closed-ended response options. The average completion time is estimated between 10 and 20 minutes.

06

What researchers measure

Primary outcomes

  1. Describe the sociodemographic profile of patients undergoing late-term abortion at Avignon Hospital.

    Time frame: Inclusion

Secondary outcomes

  1. Proportion of patients who attended the hospital for a late-term abortion following a general practitioner's recommendation.

    Time frame: Inclusion

  2. Proportion of patients who involved their general practitioner in the care pathway for late-term abortions.

    Time frame: Inclusion

  3. Descriptive analysis of patients' medical follow-up, medical history and contraceptive practices.

    Time frame: Inclusion

  4. Frequency of reasons leading to pregnancy and circumstances of pregnancy discovery.

    Time frame: Inclusion

  5. Descriptive analysis of patients' relationships with their entourage regarding this pregnancy (partner, family, healthcare professionals, etc.).

    Time frame: Inclusion

  6. Frequency of reasons for choosing abortion.

    Time frame: Inclusion

  7. Frequency of late-term abortions performed with the support of a general practitioner.

    Time frame: Inclusion

  8. Frequency of late abortions performed under coercion.

    Time frame: Inclusion

  9. Frequency of late abortions related to issues in the care pathway.

    Time frame: Inclusion

  10. Descriptive analysis of patients' difficulties in accessing this type of healthcare.

    Time frame: Inclusion

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jun 2026; primary completion for Jun 2027, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 10, 2026
First posted
Jun 16, 2026
StartEst.
Jun 15, 2026
Primary completionEst.
Jun 15, 2027
CompletionEst.
Sep 15, 2027
Last update
Jun 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07650071
Lead sponsor
Centre Hospitalier Henri Duffaut - Avignon
Responsible party
Sponsor
First posted
Jun 16, 2026
Start date
Jun 15, 2026 (estimated)
Primary completion
Jun 15, 2027 (estimated)
Completion
Sep 15, 2027 (estimated)
Last update
Jun 16, 2026

Study contacts

Marilyne Grinand, PhD
Contact
grinand.marilyne@ch-avignon.fr
(+33)432759392
Perrine Mazet, MD
principal investigator · Centre Hospitalier d'Avignon, Service de Gynécologie

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion